Irkutsk, Irkutsk region, Russian Federation
Irkutsk, Irkutsk region, Russian Federation
Irkutsk, Irkutsk region, Russian Federation
We analyzed present-day data in Russian and foreign literature on development of cytokine cascade in diffuse bacterial peritonitis having studied the role of cytokines in forming systemic inflammation response syndrome. It has been showed that cytokines primary regulate local protective response by forming typical inflammatory reaction with its classic local manifestations and natural anti-microbial resistance mechanisms. The main stage in the development of diffuse bacterial peritonitis is a disbalance in the system of proinflammatory cytokines and anti-inflammatory mediators; and this disbal-ance defines the severity of extraabdominal complications and multisystem organ failure. In the article, the markers of inflammation severity are described assisting in evaluation of the course of inflammation process and postoperative survival rate. Due to changes in immune system of the patients, it is necessary to assess complexly their immune status including cytokine profile, which in this group of patients is of diagnostic and prognostic value and needs to be further studied.
diffuse bacterial peritonitis, pathogenesis, cytokines
1. AleksandrovaYN (2007). About cytokine system [O sisteme tsitokinov]. Pediatriya, (3), 125-127
2. BudasheevVP, GarmaevBG, SodnomovChV, Sag-anovV P, HabinovBS (2012). Risk factors for septic infections at disseminated purulent peritonitis [Faktory riska gnoyno-septicheskikh infektsiy pri rasprostranen-nom gnoynom peritonite]. Bulleten’ Vostocno-Sibirskogo naucnogo centra, 4 (86), 27-28.
3. VlasovAP, RadaykinaOG, VlasovP A, ShevalaevGA, BolotskikhVA, MeleshkinAV (2015). Cytokine profile in patients with severe surgical pathology [Tsitokinovyy profil’ bol’nykh s tyazheloy khirurgicheskoy patologiey]. Sovremennye problemy nauki i obrazovaniya,(2-3), 38-42.
4. GadzhiyevNJ, KlimovaEM, NasirovMY, SushkovSV, DrozdovaLA (2012). Dynamics of cytokines in patients with generalized peritonitis [Dinamika tsitokinov u bol’nykh s rasprostranennym peritonitom]. Zabaykal ’skiy meditsinskiy vestnik,(2), 106-110.
5. .GainYM, LeontovichSI, ZavadaN VAlekseevSA, Rude-nokV V, ShakhraySV, LunevskyAV (2001). Immune status with peritonitis, and a way of its pathogenetic correction [Immunnyy status pri peritonite i puti ego patogenetich-eskoy korrektsii], 256.
6. GlobaA G, DikovaON, DemidovaVS, KarelinAA (2006). Study of blood cytokine gene expression and apoptosis fac-tors in blood and tissues of patients with surgical infections by real-time PCR [Izuchenie ekspressii genov tsitokinov i faktorov apoptoza v krovi i tkanyakh patsientov s khirur-gicheskoy infektsiey metodom PTsR real’nogo vremeni]. Biomeditsinskaya khimiya,52(6), 608-614.
7. KosinetsVA (2005). Etiopathogenic aspects of the emergence and development of a widespread purulent peritonitis [Etiopatogeneticheskie aspekty voznikno-veniya i razvitiya rasprostranennogo gnoynogo periton-ita]. Novosti khirurgii,13(1-4), 10-15.
8. KochetkovAV, GudilovMS (2015). Clinical and labo-ratory diagnostics and monitoring of septic complications after abdominal surgeries [Kliniko-laboratornaya diag-nostika i monitoring gnoyno-septicheskikh oslozhneniy posle operatsiy na organakh bryushnoy polosti]. Novosti khirurgii,23(1), 105-111.
9. MatveevaVG, GolovkinAS, GrigorievEV, Pona-senkoA V (2011). Role of the trigger receptor expressed on myeloid cells, in activation of innate immunity [Rol’ triggernogo retseptora, ekspressiruemogo na mieloid-nykh kletkakh, v aktivatsii vrozhdennogo immuniteta]. Obshchaya reanimatologiya,(7), 74.
10. PaltsevMA (1996). Cytokines. From theory to practice [Tsitokiny. Ot teorii k praktikepraktike]. Vestnik Rossiyskoy akademii nauk,66(12), 1079-1084.
11. PokrovskyEZ (2012). Analysis of the causes of deaths in widespread peritonitis [Analiz prichin letal’nykh isk-hodov pri rasprostranennom peritonite]. Vestnik Ivan-ovskoy meditsinskoy akademii,17(1), 29-32.
12. SavelyevVS, GelfandBR, FilimonovaMI (2006). Peri-tonitis [Peritonit], 25-30.
13. SeminskyIZ, SerebrennikovSN, GuzovskayaEV, Se-menovNV (2014). Role of cytokines in pathogenesis of diseases (report1) [Rol’ tsitokinov v patogeneze zabole-vaniy (soobshchenie 1)]. Sibirskiy meditsinskiy zhurnal (Irkutsk),131(8), 30-33.
14. SimbirtsevAS (2013). Cytokines in pathogenesis of infectious and non-infectious human diseases [Tsitokiny v patogeneze infektsionnykh i neinfektsionnykh zabole-vaniy cheloveka]. Meditsinskiy akademicheskiy zhurnal,13(3), 18-30.
15. FreidlinIS, StarikovaEA(2010). Endothelial cell as a target of bacteria and their components [Endotelial’naya kletka kak mishen’ deystviya bakteriy i ikh komponentov]. Meditsinskiy akademicheskiy zhurnal, 10(4), 95-106.
16. ChaginaEA, MarkelovaEV, AntsupovSN, SmirnovGA, LazanovichVA (2005). Postoperative course of peritonitis: role of cytokine imbalance [Posleoperatsionnoe techenie peritonita: rol’ tsitokinovogo disbalansa]. Dal’nevostoch-nyy meditsinskiy zhurnal, (1), 24-27.
17. BadiuDC, PaunescuV, AungurenciA, PasaricaD (2011). Proinflammatory cytokines in peritonitis. JMed Life, 4(2),158-162.
18. BanyerJ L, HamiltonNH, RamshawIA, RamsayAJ (2000). Cytokines in innate and adaptive immunity. Rev Immuno genet, 2(3), 359-373.
19. CavaillonJM (2001). Pro- versus anti-inflam-matory cytokines: myth or reality. Cell Mol Biol (Noisy-le-grand), 47(4), 695-702.
20. ChaudhryH, ZhouJ, ZhongY, AliMM, McGuireF, NagarkattiPS, NagarkattiM (2013). Role of cytokines as a double-edged sword in sepsis. In Vivo, 27(6), 669-684.
21. ColmontCS, RabyAC, DioszeghyV, LebouderE, FosterTL, JonesSA, LabétaMO, FieldingCA, TopleyN(2011). Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors. Nephrol Dial Transplant, 26(12), 4079-4090.
22. DimopoulouI, ArmaganidisA, DoukaE, MavrouI, AugustatouC, KopteridesP, LyberopoulosP, TzanelaM, OrfanosSE, PelekanouE, KostopanagiotouG, MacherasA,Giamarellos-BourboulisEJ (2007). Tumour necrosis factor-alpha (TNFalpha) and interleukin-10 are crucial mediators in post-operative systemic inflammatory re-sponse and determine the occurrence of complications after major abdominal surgery. Cytokine, 37(1), 55-61.
23. FierenMW (2012). The local inflammatory responses to infection of the peritoneal cavity in hu-mans: their regulation by cytokines, macrophages, and other leukocytes. Mediators Inflamm. 2012, 976241, doi:https://doi.org/10.1155/2012/976241.
24. HendriksT, BleichrodtRP, LommeRM, De ManBM, van GoorH, BuyneOR (2010). Peritoneal cytokines predict mortality after surgical treatment of secondary peritonitis in the rat. J Am Coll Surg, 211(2),263-270.
25. HerwigR, GlodnyB, KühleC, SchlüterB, Brink-mannO A, StrasserH, SenningerN, WindeG (2002). Early identification of peritonitis by peritoneal cytokine mea-surement. Dis Colon Rectum, 45(4), 514-521.
26. KaishoT , TakeuchiO, KawaiT, HoshinoK, AkiraS(2001). Endotoxin-induced maturation of MyD88-defi-cient dendritic cells. J Immunol, 166(9), 5688-5694.
27. KannegantiTD, LamkanfiM, NúñezG (2007). Intracellular NOD-like receptors in host defense and disease. Immunity, 27(4), 549-559.
28. KawaiT , AkiraS (2007). The role of pattern-rec-ognition receptors in innate immunity: update on Toll-like receptors. Trends Mol Med, 13(11), 460-469.
29. KimJK , ChonCY, KimJH, KimYJ, ChoJH, BangSM, AhnSH, HanKH, MoonYM (2007). Changes in serum and ascitic monocyte chemotactic protein-1 (MCP-1) and IL-10 levels in cirrhotic patients with spontaneous bacterial peritonitis. J Interferon Cytokine Res, 27(3), 227-230.
30. KumarH, KawaiT, AkiraS (2011).Pathogen recognition by the innate immune system. Int Rev Immunol, 30(1),16-34
31. LaiKN , LeungJC (2010). Inflammation in peri-toneal dialysis. Nephron Clin Pract, 116, c11-18.
32. López-CabreraM (2014). Mesenchymal conver-sion of mesothelial cells is a key event in the pathophys-iology of the peritoneum during peritoneal dialysis. Adv Med, 2014, 473134, doi:https://doi.org/10.1155/2014/473134.
33. ManteqazzaAR, ZajacAL, TwelvetreesA, Holz-baurEL, AmiqorenaS, MarksMS (2014). TLR-dependent phagosome tabulation in dendritic cells promotes pha-gosome cross-talk to optimize MHC-II antigen presenta-tion. Proc Natl Acad Sci USA, 111(43), 15508-13.
34. MartineauL, ShekPN (2000). Peritoneal cytokine concentrations and survival outcome in an experimental bacterial infusion model of peritonitis. Crit Care Med, 28(3), 788-794.
35. MarunaP, GürlichR, FraskoR, ChachkhianiI, MarunováM, OwenK, PeskováM (2002). Cytokines and soluble cytokine receptors in the perioperative period. Sb Lek, 103(2), 273-282.
36. McCullyML, ChauTA, LukeP, BlakePG, Madre-nasJ (2005). Characterization of human peritoneal den-dritic cell precursors and their involvement in peritonitis. Clin Exp Immunol, 139(3), 513-525.
37. MedzhitovR, JanewayCA (1997). Innate immu-nity: the virtues of a nonclonal system of recognition. Cell, 91(3), 295-298.
38. MeylanE, BurnsK, HofmannK, BlancheteauV, MartinonF, KelliherM, TschoppJ (2004). RIP1 is an essen-tial mediator of Toll-like receptor 3-induced NF-kappaB activation. Nat Immunol, 5(5), 503-507.
39. MutsaersSE, WilkoszS (2007). Structure and function of mesothelial cells. Cancer Treat Res, 134, 1-19.
40. OpalSM, DePaloVA (2000). Anti-inflammatory cytokines. Chest, 117(4), 1162-1172.
41. RichéF , GayatE, ColletC, MatéoJ, LaisnéMJ, Lau-nayJM, ValleurP, PayenD, CholleyBP (2013). Local and systemic innate immune response to secondary human peritonitis. Crit Care, 17( 5), R201, doi:https://doi.org/10.1186/cc12895.
42. SanzAB , AroeiraLS, BellonT, del PesoG,Jimenez-HeffernanJ, SantamariaB, Sanchez-NiñoMD, Blanco-ColioLM, Lopez-Cabrera M, Ruiz-Ortega M, Egido J, SelgasR, OrtizA (2014). TWEAK promotes peritoneal inflammation. PLoS One, 9(3): e90399. doihttps://doi.org/10.1371/journal.pone.0090399.
43. ScheingraberS, BauerfeindF, BöhmeJ, DralleH (2001). Limits of peritoneal cytokine measurements during abdominal lavage treatment for intraabdominal sepsis. Am J Surg, 181(4), 301-308.
44. SeeleyJ J, GhoshS (2013). Tolerization of inflam-matory gene expression. Cold Spring HarbSymp Quant Biol, 78, 69-79.
45. ShihRH, WangCY, YangCM (2015). NF-kappaB signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci, 8, 77.
46. WeissDS, RaupachB, TakedaK, AkiraS, Zychlin-skyA (2004). Toll-like receptors are temporally involved in host defense. J Immunol, 172(7), 4463-4469.
47. XiaoZ , WilsonC, RobertsonHL, RobertsDJ, BallCG, JenneC N, KirkpatrickAW (2015). Inflammatory mediators in intra-abdominal sepsis or injury - a scoping review. Crit Care, 19, 373. doi:https://doi.org/10.1186/s13054-015-1093-4.
48. YungS, Chan TM (2012). Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells. Mediators In-flamm, 2012, 484167.
49. YungS, ChanTM (2009). Intrinsic cells: meso-thelial cells - central players in regulating inflammation and resolution. Perit Dial Int, 29Suppl 2, S21-27.
